3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific RecognitionJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-12-2921PREAI
Synthesis, Pharmacological, and Biological Evaluation of 2-FuroylBased MIF-1 Peptidomimetics and the Development of a GeneralPurpose Model for Allosteric Modulators (ALLOPTML)ACS CHEMICAL NEUROSCIENCEIF3.92020-12-2112OA
Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific RecognitionJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-09-2615PREAI
Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New L-Prolyk-L-leucyl-glycinamide PeptidomimeticsACS CHEMICAL NEUROSCIENCEIF3.92018-05-2343OAAI
Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective AntagonistsJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-08-2114PREAI
Pyrazin-2(1H)-ones as a novel class of selective A3 adenosine receptor antagonistsFUTURE MEDICINAL CHEMISTRYIF3.42015-07-317PREAI
Synthesis by microwave-assisted 1,3-dipolar cycloaddition of 1,2,3-triazole 1′-homo-3′-isoazanucleosides and evaluation of their anticancer activityEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92015-06-0114PREAI
Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of L-prolyl-L-leucyl-glycinamide (PLG) modified in the L-proline or L-proline and L-leucine scaffolds在L-脯氨酸或L-脯氨酸和L-亮氨酸支架中修饰的L-脯氨酰-L-亮氨酰-甘氨酰胺 (PLG) 的肽类似物的合成和对多巴胺受体的变构调节EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-11-0118PREAI
Model for High-Throughput Screening of Multitarget Drugs in Chemical Neurosciences: Synthesis, Assay, and Theoretic Study of Rasagiline CarbamatesACS CHEMICAL NEUROSCIENCEIF3.92013-07-2960OA
Copper-Catalyzed Huisgen 1,3-Dipolar Cycloaddition under Oxidative Conditions: Polymer-Assisted Assembly of 4-Acyl-1-Substituted-1,2,3-TriazolesJOURNAL OF ORGANIC CHEMISTRYIF3.62013-06-1426PRE
TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseasesBIOORGANIC & MEDICINAL CHEMISTRYIF32013-04-0180PRE
Using entropy of drug and protein graphs to predict FDA drug-target network: Theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepaticaEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92011-04-0161PREAI
MIND-BEST: Web Server for Drugs and Target Discovery; Design, Synthesis, and Assay of MAO-B Inhibitors and Theoretical-Experimental Study of G3PDH Protein from Trichomonas gallinaeJOURNAL OF PROTEOME RESEARCHIF3.62011-04-0184PREAI
Pyrimidine Derivatives as Potent and Selective A3 Adenosine Receptor AntagonistsJOURNAL OF MEDICINAL CHEMISTRYIF6.82010-12-2758PREAI
Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonistsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92010-07-016PREAI
Polymer-Supported 1,5,7-Triazabicyclo[4.4.0]dec-5-ene as Polyvalent Ligands in the Copper-Catalyzed Huisgen 1,3-Dipolar CycloadditionADVANCED SYNTHESIS & CATALYSISIF42010-05-0584PREAI
Synthesis and pharmacological evaluation of novel 1,3,8-and 1,3,7,8-substituted xanthines as adenosine receptor antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32010-03-016PRE
Synthesis and pharmacological evaluation of novel 1-and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32009-09-0112PRE
Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A2B receptor antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32009-05-0119PREAI
1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationshipsBIOORGANIC & MEDICINAL CHEMISTRYIF32009-05-0114PRE